SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-17-002122
Filing Date
2017-08-14
Accepted
2017-08-14 17:10:59
Documents
48
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q xenetic_10q-063017.htm 10-Q 287894
2 FORM OF INDEMNITY AGREEMENT xenetic_10q-ex1001.htm EX-10.1 57691
3 CERTIFICATION xenetic_10q-ex3101.htm EX-31.1 8358
4 CERTIFICATION xenetic_10q-ex3102.htm EX-31.2 8081
5 CERTIFICATION xenetic_10q-ex3201.htm EX-32.1 4064
  Complete submission text file 0001683168-17-002122.txt   1642784

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE xbio-20170630.xml EX-101.INS 175819
7 XBRL SCHEMA FILE xbio-20170630.xsd EX-101.SCH 22490
8 XBRL CALCULATION FILE xbio-20170630_cal.xml EX-101.CAL 37144
9 XBRL DEFINITION FILE xbio-20170630_def.xml EX-101.DEF 73854
10 XBRL LABEL FILE xbio-20170630_lab.xml EX-101.LAB 156599
11 XBRL PRESENTATION FILE xbio-20170630_pre.xml EX-101.PRE 126453
Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37937 | Film No.: 171031483
SIC: 2834 Pharmaceutical Preparations